NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
8.56
-0.36 (-4.04%)
At close: Mar 10, 2026, 4:00 PM EDT
8.49
-0.07 (-0.82%)
Pre-market: Mar 11, 2026, 6:11 AM EDT

NeoGenomics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,1111,5172,1122,0611,1734,235
Market Cap Growth
-22.07%-28.17%2.48%75.74%-72.31%-29.82%
Enterprise Value
1,3611,9222,4932,2521,3394,324
Last Close Price
8.5611.7616.4816.189.2434.12
PE Ratio
--14.00-26.58-23.11-7.97-487.43
Forward PE
54.1283.58103.91---
PEG Ratio
1.74-----
PS Ratio
1.532.093.203.482.308.74
PB Ratio
1.321.812.342.191.183.82
P/TBV Ratio
1.311.802.312.161.153.69
P/FCF Ratio
--69.65-62.04-67.12-12.10-46.60
P/OCF Ratio
212.47290.04300.70-1055.21-17.77-158.46
EV/Sales Ratio
1.872.643.773.812.638.93
EV/EBITDA Ratio
--39.99-127.47-64.05-15.18-66.11
EV/EBIT Ratio
--16.58-27.07-20.90-8.49-36.41
EV/FCF Ratio
--88.24-73.25-73.33-13.82-47.59
Debt / Equity Ratio
0.480.480.440.640.610.55
Debt / EBITDA Ratio
-8.52-8.52-30.95-17.40-6.93-9.37
Debt / FCF Ratio
-18.80-18.80-17.78-19.92-6.31-6.74
Net Debt / Equity Ratio
0.490.490.650.210.170.09
Net Debt / EBITDA Ratio
-8.52-8.52-29.93-5.59-1.96-1.49
Net Debt / FCF Ratio
-18.80-18.80-17.20-6.40-1.78-1.07
Asset Turnover
0.770.770.500.350.280.34
Inventory Turnover
--30.6714.3313.5011.23
Quick Ratio
-00.075.676.207.19
Current Ratio
0.240.240.136.206.737.81
Return on Equity (ROE)
-12.42%-12.42%-8.54%-9.07%-13.70%-0.93%
Return on Assets (ROA)
-12.00%-12.00%-6.75%-5.71%-7.91%-4.60%
Return on Invested Capital (ROIC)
-13.41%-13.41%-8.80%-8.12%-11.39%-6.88%
Return on Capital Employed (ROCE)
-15.42%-15.42%-8.13%-6.66%-9.18%-8.80%
Earnings Yield
-9.72%-7.14%-3.76%-4.33%-12.55%-0.21%
FCF Yield
-1.96%-1.44%-1.61%-1.49%-8.26%-2.15%
Buyback Yield / Dilution
-0.06%-0.06%-0.22%-0.22%-1.07%-9.99%
Updated Feb 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q